03/11/2026
The new platform, called FDA Adverse Event Monitoring System (AEMS), would include adverse-event reports submitted to the U.S. health regulator for drugs, biologics, vaccines, cosmetics and animal food on a single, streamlined dashboard.
The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to streamline the analysis of reports on drug side effects.